MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 422 filers reported holding MEDIVATION INC in Q2 2016. The put-call ratio across all filers is 0.92 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2016 | $329,000 | +327.3% | 5,460 | +225.6% | 0.01% | +300.0% |
Q1 2016 | $77,000 | -4.9% | 1,677 | 0.0% | 0.00% | -25.0% |
Q4 2015 | $81,000 | +39.7% | 1,677 | +23.6% | 0.00% | -20.0% |
Q3 2015 | $58,000 | +866.7% | 1,357 | +2669.4% | 0.01% | – |
Q2 2015 | $6,000 | 0.0% | 49 | 0.0% | 0.00% | – |
Q1 2015 | $6,000 | 0.0% | 49 | -22.2% | 0.00% | -100.0% |
Q4 2014 | $6,000 | 0.0% | 63 | -3.1% | 0.00% | 0.0% |
Q3 2014 | $6,000 | -75.0% | 65 | -79.4% | 0.00% | -66.7% |
Q2 2014 | $24,000 | -40.0% | 315 | -50.0% | 0.00% | 0.0% |
Q1 2014 | $40,000 | – | 630 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 2,484,101 | $158,535,000 | 79.84% |
Cormorant Asset Management, LP | 546,900 | $34,903,000 | 10.13% |
BB BIOTECH AG | 1,479,706 | $94,435,000 | 5.04% |
PFM Health Sciences, LP | 2,719,859 | $173,581,000 | 3.49% |
Partner Investment Management, L.P. | 219,981 | $14,039,000 | 3.19% |
Orbimed Advisors | 3,123,500 | $199,342,000 | 2.93% |
Antipodean Advisors LLC | 525,000 | $33,506,000 | 2.90% |
Eventide Asset Management | 134,800 | $8,603,000 | 2.65% |
Bain Capital Public Equity Management, LLC | 1,428,117 | $91,142,000 | 2.58% |
BENNETT LAWRENCE MANAGEMENT L L C/NY | 257,055 | $16,405,000 | 2.52% |